Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epacadostat vs Tamoxifen in Biochemical-Recurrent Ovarian Cancer
NCT01685255Phase 2Terminated
- Sponsor
- Incyte
- Start
- Aug 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of epacadostat in ovarian cancer, primary peritoneal carcinoma (PPC), fallopian tube cancer (PFTC), sponsored by Incyte. Started Aug 2012; status: terminated.
02
Drugs
epacadostat
03
Conditions
ovarian cancerprimary peritoneal carcinoma (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT01685255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01685255.